Oruka Therapeutics Files 2024 Annual Report
Ticker: ORKA · Form: 10-K · Filed: Mar 6, 2025 · CIK: 907654
| Field | Detail |
|---|---|
| Company | Oruka Therapeutics, Inc. (ORKA) |
| Form Type | 10-K |
| Filed Date | Mar 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceutical
TL;DR
Oruka Therapeutics filed its 2024 10-K. Check financials.
AI Summary
Oruka Therapeutics, Inc. filed its annual report on Form 10-K for the fiscal year ended December 31, 2024. The company, previously known as ARCA biopharma, Inc., NUVELO INC, and HYSEQ INC, is headquartered at 855 Oak Grove Ave., Suite 100, Menlo Park, CA 94025. The filing was made on March 6, 2025, under SEC file number 000-22873.
Why It Matters
This 10-K filing provides a comprehensive overview of Oruka Therapeutics' financial performance and business operations for the fiscal year 2024, crucial for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a standard annual report filing and does not contain specific new risk disclosures beyond what is typical for a public company.
Key Players & Entities
- Oruka Therapeutics, Inc. (company) — Registrant
- December 31, 2024 (date) — Fiscal year end
- March 6, 2025 (date) — Filing date
- 000-22873 (dollar_amount) — SEC file number
- ARCA biopharma, Inc. (company) — Former company name
- NUVELO INC (company) — Former company name
- HYSEQ INC (company) — Former company name
- 855 Oak Grove Ave., Suite 100, Menlo Park, CA 94025 (company) — Business address
FAQ
What is the primary purpose of this filing?
This filing is an Annual Report on Form 10-K for the fiscal year ended December 31, 2024, providing a comprehensive overview of Oruka Therapeutics, Inc.'s business and financial condition.
When was this 10-K filed with the SEC?
This 10-K was filed on March 6, 2025.
What is Oruka Therapeutics, Inc.'s SEC file number?
Oruka Therapeutics, Inc.'s SEC file number is 000-22873.
What is the company's business address?
The company's business address is 855 Oak Grove Ave., Suite 100, Menlo Park, CA 94025.
Has Oruka Therapeutics, Inc. operated under other names previously?
Yes, the company was formerly known as ARCA biopharma, Inc., NUVELO INC, and HYSEQ INC.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 6, 2025 regarding Oruka Therapeutics, Inc. (ORKA).